Axon Enterprise, Inc (NASDAQ:AXON – Get Free Report) CEO Patrick Smith sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $643.79, for a total value of $6,437,900.00. Following the completion of the sale, the chief executive officer owned 3,040,997 shares in the company, valued at approximately $1,957,763,458.63. This represents a 0.33% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Axon Enterprise Price Performance
Shares of NASDAQ:AXON opened at $582.00 on Friday. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $885.91. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. The company has a market cap of $46.91 billion, a PE ratio of 233.73, a price-to-earnings-growth ratio of 12.24 and a beta of 1.38. The company’s 50 day moving average is $454.59 and its 200 day moving average is $483.19.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating the consensus estimate of $1.60 by $0.01. The business had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.90 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The business’s quarterly revenue was up 33.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.47 EPS. On average, sell-side analysts forecast that Axon Enterprise, Inc will post 1.63 EPS for the current year.
Axon Enterprise News Summary
- Positive Sentiment: Axon was upgraded to Zacks Rank #1 (Strong Buy), reflecting improved earnings optimism and a potentially more favorable outlook for the shares. Article: Axon (AXON) Upgraded to Strong Buy: Here’s What You Should Know
- Positive Sentiment: Investor attention remains high, with heavy searching on Zacks and recent coverage highlighting Axon’s strong growth narrative and expanding law-enforcement contracts. Article: Investors Heavily Search Axon Enterprise, Inc (AXON): Here is What You Need to Know
- Positive Sentiment: Recent articles pointed to record quarterly revenue, AI-driven public safety products, and contract wins such as increased spending from the Los Angeles Police Department, reinforcing the company’s growth story. Article: Why Axon Enterprise (AXON) Is Up 14.2% After Trump Stake And New ICE Contract Momentum
- Neutral Sentiment: CEO Patrick W. Smith sold 10,000 shares under a pre-arranged 10b5-1 plan, which is routine insider selling and not necessarily a negative signal, though it may still draw investor attention. Article: SEC filing for insider sale
- Neutral Sentiment: Some commentary says Axon may be looking fully valued after its sharp run-up, and one report noted the stock underperformed peers on Wednesday, which could limit upside if growth expectations cool. Article: Axon Enterprise (AXON) Following Its Public Safety Platform Narrative Looks Fully Valued
Wall Street Analyst Weigh In
Several brokerages have weighed in on AXON. The Goldman Sachs Group set a $535.00 price target on Axon Enterprise in a research report on Thursday, May 7th. Piper Sandler restated an “overweight” rating and issued a $674.00 target price on shares of Axon Enterprise in a research note on Monday, June 15th. Morgan Stanley set a $600.00 target price on Axon Enterprise in a report on Thursday, May 7th. TD Cowen reduced their price target on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating for the company in a research report on Wednesday, April 8th. Finally, Barclays decreased their price target on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating for the company in a report on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $722.12.
Get Our Latest Stock Analysis on AXON
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Rockefeller Capital Management L.P. lifted its holdings in Axon Enterprise by 53.2% in the 4th quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock valued at $6,542,000 after purchasing an additional 4,002 shares in the last quarter. Legal & General Group Plc grew its holdings in shares of Axon Enterprise by 1.3% during the fourth quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock worth $242,241,000 after buying an additional 5,419 shares in the last quarter. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $13,116,000. Wealth Enhancement Advisory Services LLC raised its position in shares of Axon Enterprise by 93.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 23,365 shares of the biotechnology company’s stock valued at $13,270,000 after buying an additional 11,262 shares during the last quarter. Finally, Teamwork Financial Advisors LLC raised its position in shares of Axon Enterprise by 40.5% in the fourth quarter. Teamwork Financial Advisors LLC now owns 25,352 shares of the biotechnology company’s stock valued at $14,398,000 after buying an additional 7,307 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.
About Axon Enterprise
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Stories
- Five stocks we like better than Axon Enterprise
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg){kind=logo}
